Recently, Precision ADVANCE’s Anshul Mangal moderated “Considerations for Early-Stage Gene Therapy Start-Ups: From Clinical Development to Manufacturing to Commercialization,” at the Gene Therapy for Rare Disorders virtual conference.
Project Farma’s Tony Khoury and Precision’s Philip Cyr and David Parker joined a panel of industry experts for an update on the status of their current pipelines and development process, as well as a discussion of their unique experiences leading early-stage gene therapy companies, the challenges they faced and lessons learned.
Download a summary of the insightful panel discussion here!